Dimension prices $71.5 million initial public stock offering at $13.00

Company to sell stock through bookrunners Goldman Sachs, Citigroup

By Devika Patel

Knoxville, Tenn., Oct. 22 – Dimension Therapeutics, Inc. said it priced its $71.5 million initial public sale of stock with a $10.73 million greenshoe on Wednesday.

The company will sell 5.5 million common shares at $13.00 apiece.

Goldman, Sachs & Co. and Citigroup Global Markets Inc. are the bookrunning managers.

The gene therapy company is based in Cambridge, Mass. The company’s expects its shares will trade on the Nasdaq under the symbol “DMTX.”

Issuer:	Dimension Therapeutics, Inc.
Issue:	Common stock
Amount:	$71.5 million
Greenshoe:	$10,725,000, or 825,000 shares
Shares:	5.5 million
Price:	$13.00
Warrants:	No
Bookrunners:	Goldman, Sachs & Co. and Citigroup Global Markets Inc.
Lead manager:	Wells Fargo Securities, LLC
Co-managers:	Canaccord Genuity Inc. and Cantor Fitzgerald & Co.
Pricing date:	Oct. 21
Stock exchange:	Nasdaq: DMTX

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.